Combination therapy with immune check point inhibitors and acute kidney injury.

Acta oncologica (Stockholm, Sweden)(2023)

引用 1|浏览5
暂无评分
摘要
Patients receiving combination therapy with checkpoint inhibitors are at high risk of AKI, but different causes of AKI should always be considered. Use of PPI concurrently with ICIs is likely to increase the risk of AKI.
更多
查看译文
关键词
Checkpoint inhibitors,acute kidney injury,combination therapy,nephrotoxicity
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要